Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588–606.

Article  CAS  PubMed  Google Scholar 

Sun T, Xie R, He H, Xie Q, Zhao X, Kang G, et al. Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35. Front Immunol. 2022;13:1019365.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2024;23:43–66.

Article  CAS  PubMed  Google Scholar 

Sydnes OA. A clinical investigation of niflumic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol Suppl. 1973;1:8–11.

Article  CAS  PubMed  Google Scholar 

White MM, Aylwin M. Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes. Mol Pharmacol. 1990;37:720–4.

Article  CAS  PubMed  Google Scholar 

Liantonio A, Giannuzzi V, Picollo A, Babini E, Pusch M, Conte Camerino D. Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium. Br J Pharmacol. 2007;150:235–47.

Article  CAS  PubMed  Google Scholar 

Smith CE, Soti S, Jones TA, Nakagawa A, Xue D, Yin H. Non-steroidal anti-inflammatory drugs are caspase inhibitors. Cell Chem Biol. 2017;24:281–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eisenstein A, Hilliard BK, Pope SD, Zhang C, Taskar P, Waizman DA, et al. Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs. Immunity. 2022;55:1082–95. e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.

Article  CAS  PubMed  Google Scholar 

Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440:228–32.

Article  CAS  PubMed  Google Scholar 

Shimizu T, Iehara T, Sato K, Fujii T, Sakai H, Okada Y. TMEM16F is a component of a Ca2+-activated Cl- channel but not a volume-sensitive outwardly rectifying Cl- channel. Am J Physiol Cell Physiol. 2013;304:C748–59.

Article  CAS  PubMed  Google Scholar 

Lee B, Hong GS, Lee SH, Kim H, Kim A, Hwang EM, et al. Anoctamin 1/TMEM16A controls intestinal Cl(-) secretion induced by carbachol and cholera toxin. Exp Mol Med. 2019;51:1–14.

PubMed  PubMed Central  Google Scholar 

da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390:E21–33.

Article  PubMed  Google Scholar 

Daniels MJ, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models. Nat Commun. 2016;7:12504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Green JP, Yu S, Martin-Sanchez F, Pelegrin P, Lopez-Castejon G, Lawrence CB, et al. Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc Natl Acad Sci U S A. 2018;115:E9371–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Yi X, Zhao B, Zhi Y, Xu Z, Cao Y, et al. The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function. Pharmacol Res. 2023;198:107016.

Article  CAS  PubMed  Google Scholar 

Green JP, Swanton T, Morris LV, El-Sharkawy LY, Cook J, Yu S et al. LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation. Elife 2020;9:e59704.

Yang G, Tang X, Tan L, Nong D, Yang P, Ning H. Upregulation of miR-144-3p protects myocardial function from ischemia-reperfusion injury through inhibition of TMEM16A Ca(2+)-activated chloride channel. Hum Cell. 2021;34:360–71.

Article  CAS  PubMed  Google Scholar 

Cui ZQ, Hu XY, Yang T, Guan JW, Gu Y, Li HY, et al. TMEM16F may be a new therapeutic target for Alzheimer’s disease. Neural Regen Res. 2023;18:643–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ousingsawat J, Wanitchakool P, Kmit A, Romao AM, Jantarajit W, Schreiber R et al. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X receptors in macrophages. Nat Commun 2015;6:6245.

Karmakar M, Katsnelson MA, Dubyak GR, Pearlman E. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1beta secretion in response to ATP. Nat Commun. 2016;7:10555.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ousingsawat J, Wanitchakool P, Schreiber R, Kunzelmann K. Contribution of TMEM16F to pyroptotic cell death. Cell Death Dis. 2018;9:300.

Article  PubMed  PubMed Central  Google Scholar 

Wu N, Cernysiov V, Davidson D, Song H, Tang J, Luo S, et al. Critical role of lipid scramblase TMEM16F in phosphatidylserine exposure and repair of plasma membrane after pore formation. Cell Rep. 2020;30:1129–e11405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pedemonte N, Galietta LJ. Structure and function of TMEM16 proteins (anoctamins). Physiol Rev. 2014;94:419–59.

Article  CAS  PubMed  Google Scholar 

Ye Z, Galvanetto N, Puppulin L, Pifferi S, Flechsig H, Arndt M, et al. Structural heterogeneity of the ion and lipid channel TMEM16F. Nat Commun. 2024;15:110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng S, Puchades C, Ko J, Wu H, Chen Y, Figueroa EE, et al. Identification of a drug binding pocket in TMEM16F calcium-activated ion channel and lipid scramblase. Nat Commun. 2023;14:4874.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le T, Jia Z, Le SC, Zhang Y, Chen J, Yang H. An inner activation gate controls TMEM16F phospholipid scrambling. Nat Commun. 2019;10:1846.

Article  PubMed